Abstract:AIMS:The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery.MATERIALS AND METHODS:mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted.RESULTS:The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs.CONCLUSION:The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed.

Gelatin-based anticancer drug delivery nanosystems: A mini review

Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.

Chemical and Structural Engineering of Gelatin-Based Delivery Systems for Therapeutic Applications: A Review

Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery

Current Trends in Gelatin-Based Drug Delivery Systems

PLLAGrafted Gelatin Amphiphilic Copolymer and Its SelfAssembled Nano Carrier for Anticancer Drug Delivery

Smart nanogels for cancer treatment from the perspective of functional groups

Nanoparticle-based drug delivery systems for cancer therapy

Cancer Cell Membrane Camouflaged Biomimetic Gelatin-Based Nanogel for Tumor Inhibition

Advances in cancer diagnosis and therapy by alginate-based multifunctional hydrogels: A review

Recent advances in nanogels composed of dendrimers to tackle cancer

Application of Hydrogels as Carrier in Tumor Therapy: A Review

Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery

Size-transformable nanoparticles with sequentially triggered drug release and enhanced penetration for anticancer therapy

Hydrogel-Based Controlled Drug Delivery For Cancer Treatment: A Review

Recent Progress in the Design and Application of Supramolecular Peptide Hydrogels in Cancer Therapy

Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin

Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges

Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges

Nano-Gels: Recent Advancement in Fabrication Methods for Mitigation of Skin Cancer

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles